Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Legal Topics Similar Videos
Behavioral sciences approach to risk management
Amanda Raad, co-chair of Ropes & Gray’s anti-corruption & international risk practice, discusses the new data-driven behavioral sciences approach to risk management.
U.S. International Trade Commission
Matt Rizzolo, Ropes & Gray IP litigation partner, examines the various operations of the U.S. International Trade Commission (USITC) in an increasingly global world.
Section 101: confusion over patentable subject matter
Matt Rizzolo, Ropes & Gray IP litigation partner, addresses the ongoing confusion over what constitutes patentable subject matter under Section 101 of the Patent Act.
Drug pricing initiatives during the Trump presidency
Tom Bulleit, Ropes & Gray health care partner, discusses the Trump Administration’s latest drug pricing initiatives.
False Claims Act: three years after Escobar
Kirsten Mayer, Ropes & Gray litigation partner, provides an update on the False Claims Act (FCA), three years after the Supreme Court’s decision on Universal Health Services v. U.S. ex rel. Escobar.
Impact of changes at the PTAB on patent owners
Scott McKeown, Ropes & Gray IP litigation partner and chair of the firm’s Patent Trial and Appeal Board (PTAB) group, examines how some recent changes at the PTAB will benefit patent owners.